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There is not in Argentina publications regarding the presentation of patients with COVID‑19 requiring 
hospitalized and emergency care in vulnerable populations (lower incomes and less education tend 
at greater risk for poor health status and healthcare access), and it has few reports in developing 
countries. The objective is to determine whether in the care of vulnerable patients, to succeed against 
COVID‑19, multiple public health tools and interventions will be needed to minimize morbidity and 
mortality. The study is a prospective cohort investigation of patients with lab‑confirmed COVID‑19, 
who required to any of the Health Centers response from April 8, 2020, to August 18, 2020. In Buenos 
Aires Metropolitan Area (AMBA), April 8, 2020 the virus was identified in patients hospitalized in the 
"Southeast Network" (SN), AMBA. SN covering an area of 661 square kilometers, with 1.8 million 
inhabitants residing in urban, and rural areas. A total of 14 health centers with different levels of care 
complexity provide care to patients in the region. The information of each patient with COVID‑19 
evaluated by SN, was incorporated in an Epidemiological Dashboard. The investigation was designed 
and reported with consideration of observational studies in epidemiology. We describe the hospitals 
presentation and care of persons who required SN response and were ultimately diagnosed with 
COVID‑19. From April 8, 2020, to August 18, 2020, were included 1495 patients with lab‑confirmed 
COVID‑19 in SN. A total of 58% patients were men, and the mean age (SD) was 48.9 (15.59) years. 
Eighty one percent patients with pre‑existing diseases, most frequent hypertension and diabetes, 
but hypertension, chronic lung disease, and cardiovascular disease presented higher risk. A total of 
13% were hospitalized in Intensive Therapy Unit. The mortality of the cohort was 9.77%. Mortality 
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was higher for patients aged 65 or more (OR 5.09), and for those had some pre‑existing disease (OR 
2.61). Our observations are consistent with reports demonstrating older persons, and those with 
comorbidities have the highest risk of mortality related to COVID‑19. However, unlike other reports 
from developed or some developing countries, the mortality in our study is lower. This finding may 
be related to age of our cohort is younger than other published. Also, the health system was able to 
respond to the demand.
Abbreviations
AMBA  Buenos Aires Metropolitan
SN  Area Southeast Network
HEC  El Cruce Hospital N Kirchner
ITU  Therapy Unit
GWo  General Ward with oxygen therapy
GW  General Ward stay
ID  Identification of patient
The coronavirus disease 2019 (COVID-19) pandemic was first reported in Hubei Province, China, in December 
 20191. The initial Argentina case of COVID-19 was reported on March 3,  20202, in Buenos Aires Metropolitan 
Area (AMBA)3. In April 8, 2020 the virus was identified in patients hospitalized in the "Southeast Network", 
AMBA. The Hospital "El Cruce, Néstor Kirchner" (HEC), following the modality of network implemented since 
its creation in 2007, organized a network system with the Health Centers of the region especially for the pan-
demic, named "South East Network "4. Subsequently, lab-confirmed cases of COVID-19 increased exponentially 
in AMBA area, also but lesser extent, in other parts of Argentina.
Although the clinical profile of patients has been  reported5–7, no publications in Argentina regarding the 
presentation of patients with COVID-19 requiring hospitalized and emergency care in vulnerable populations.
In developing countries, especially in the care of vulnerable patients, to succeed against COVID-19, multiple 
public health tools and interventions will be needed to minimize morbidity and mortality related to COVID19. 
Although extreme public health interventions, for example, lockdowns and stay-at-home mandates, were initially 
critical to flattening the curve. Since the beginning of the pandemic in light of the situation reported in countries 
that have begun the pandemic before in  Argentina8–10, it decide to create a Southeast Network in order to remedy 
the inefficiencies in the management of information and coordination between the different public (unpaid) 
health institutions in the region, and increase the number of available hospital beds and human resources.
In this study, we describe the hospitals presentation and care of persons who required Southeast Network 
(SN) response and were ultimately diagnosed with COVID-19 to offer actionable understandings to help to 
inform best practice.
Methods
Study design, setting, and population. The study is a prospective cohort investigation of patients with 
lab-confirmed COVID-19 in SN, who required to any of the Centers response from April 8, 2020, to August 18, 
2020. The recruitment was consecutive.
We used a flow chart, following the STROBE  guidelines11. The evaluation of the patient begins with the 
triage in emergency room, where the patient is classified as a suspected case of COVID-19. Swabbing for PCR 
determination of SARS-CoV-2 is performed.
While waiting for the PCR result, the patient is considered to be infected with SARS-CoV-2 and all precau-
tions for personal protection and patient isolation are taken.
The clinical, laboratory and radiological evaluation is carried out.
The severity of the clinical picture is classified to determine the place of hospitalization and indicate the 
treatment.
The inclusion criteria were hospitalized patients, in the first stage of the study, patients with suspected and 
confirmed COVID were admitted. But in the data analysis, only patients with a confirmed diagnosis of COVID-
19 by PCR determination of SARS-CoV-2 in nasopharyngeal exudate were included. Excluded criteria was 
patients without a confirmed diagnosis of COVID-19 and not hospitalized.
The investigation was designed and reported with consideration of observational studies in epidemiology 
reporting guideline of Health Ministry of Province of Buenos Aires (http:// www. ms. gba. gov. ar/ ssps/ inves tigac ion/ 
DocTe cnicos/ TipoI nvest igaci ones- Ident ifica cionr iesgos. pdf. Accessibility verified August 24, 2020.) 12. Because 
the investigation was considered minimal risk, the requirement for consent was only verbal to patients or their 
relatives. (Ethics Committee, El Cruce Hospital N Kirchner).
All experimental protocols of the study were approved by the ethics committee of ’Hospital El Cruce’, 
Argentina.
COVID-19 was diagnosed by real-time reverse transcription–polymerase chain reaction (RT-PCR) detec-
tion of SARS-CoV-2 from nasopharyngeal swabs. Molecular techniques based RT-PCR are considered the gold 
standard for COVID-19 diagnosis, real-time RT-PCR detects amplified SARS-CoV-2  genome13.
The RT-PCR determination was centralized in two Laboratories (El Cruce Hospital, and National Quilmes 
University), it has been common to all patients. Test results were available a median 1–3 days after the SN 
encounter.
SN is a large periurban region, covering an area of 661 square kilometers, with 1.8 million inhabitants resid-
ing in urban, suburban, and rural areas. Argentina is considered a developing country with a high human 
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development index (0.830 in 2018), however there are significant structural development gaps and heterogenei-
ties between different areas. The municipalities of the southeast region are located in the lowest ranking of the 
municipalities of the Province of Buenos  Aires4. A total of 14 health centers with different levels of care complex-
ity provide care to patients in the region. The Centers are administered by the Ministry of Health of the Nation, 
by Province of Buenos Aires, of both, and by Municipalities (Supplementary appendix).
The SN medical response is 2 tiered. The first tier is provided by medical doctors (MD) in Emergency Room 
of each Health Center, all patients go to the emergency room, and majority consult spontaneously in the Center 
of their neighborhoods.
If the patients had symptoms compatibles con COVID-19 and more severe illness, it was decided whether 
they should be hospitalized as suspected. The second-tier response in confirmed cases comprises also MD in 
Intensive Therapy Unit (ITU) stay, or General Ward with oxygen therapy (GWo), or General Ward (GW) stay.
Ethical approval. The investigation was designed and reported with consideration of observational studies 
in epidemiology reporting guideline of Health Ministry of Province of Buenos Aires. Because the investigation 
was considered minimal risk, the requirement for consent was only verbal to patients or their relatives. All 
experimental protocols of the study were approved by the ethics committee of ’Hospital El Cruce’, Argentina.
Consent for publication. I confirm because the investigation was considered minimal risk, the require-
ment for consent was only verbal to patients or their relatives. (Ethics Committee, El Cruce Hospital N Kirch-
ner).
Data sources
The information of each patient with COVID-19 evaluated by SN, was incorporated in an Epidemiological 
Dashboard, created by specialists (CI, BL) from the design of software especially for this project. The current 
investigation used from April 8, the electronic medical record incorporated the diagnosis of COVID-19, sus-
pected or known. In a first stage, a "window" was established that allowed the visualization of the occupation 
and availability of beds by establishment and by sector. In the Dashboard each patient had an identification (ID) 
generated automatically, name, identity document and address, gender, age, date of admission are incorporated, 
the system automatically generates the days of hospitalization. Clinical risk was adapted from the National Health 
Ministry  guidelines14, in three categories. Mild, when patients have unilateral radiological involvement and  SatO2 
is  > 95%, the Internment in WGo, or WG is decided.
Moderate, when radiological involvement is bilateral, patients saturate below 95%, they are admitted to 
WGo. Severe, when they present ATS/IDSA (American Thoracic Society-ATS) (Infectious Diseases Society of 
America -IDSA-) criteria: one of two major (-Need for invasive MRA- Septic shock) or three minor (-Tachypnea 
≥ 30/min.-  PaO2/FiO2 < 250, Confusion/disorientation Multilobar infiltrates, Urea> 42 mg/100 ml, Leukope-
nia (<4000/mm3), Plaquetopenia (< 100,000/mm3), Temperature < 36 °C, Hypotension requiring aggressive 
hydration). They are admitted to ITU. The safe discharge for the patient and for third parties, was used for those 
patients who in case of being discharged from hospital, could not return home, because they did not have or 
because they lived in crowded conditions, and could not be isolated. A socio-economic and food security survey 
was started, but its analysis was not yet completed, for this reason it was not included in this study.
As the Dashboard and the software is a new instrument, a help desk was implemented on the use of the 
software. From the beginning a monitoring and follow-up of the data entry was organized twice a day, morning 
and night, by the HEC technical team (DAV, OL, YA). A "Procedures Manual" was prepared and distributed 
among the users of the Project.
Statistical analysis. We analyzed the distribution of the characteristics of the entire hospitalized popula-
tion and it was stratified by type of bed (ITU, WGo, WG). The characteristics in relation to clinical and safe dis-
charge were compared, we used descriptive statistics, χ2 and Fisher’s exact test for categorical variables, and t and 
Wilcoxon’s test for continuous variables. Also, to analyze risk factors, we used multivariate analysis and logistic 
regression. All analyzes were performed using SPSS version 24 statistical software (IBM Corp). A P ≤ 0.05 was 
considered statistically significant, all the tests were 2- tailed.
Results
From April 8, 2020, to August 18, 2020, 1,495 patients with lab-confirmed COVID-19 in SN were included.
At the start of pandemic, March 2020, the SN had 67 beds in ITU, and now 156 beds are available, an increase 
of 133% (Fig. 1). It also increased in GWo area from 142 to 378 beds, an expansion of 166% (Fig. 1), and in GW 
area from 143 to 191 beds, an increase of 34%.
We did not have extra-hospital isolation beds in the NS. This space began to be incorporated for the first 
time to the Health Service from the need to have places that allow to have patients with suspected or diagnosed 
COVID-19 that did not require medical care, but that had to be isolated to avoid contagion to their contacts, 
and that they could not stay in their homes, because they did not have house or because they did not meet the 
appropriate conditions for isolation. We have 883 extra-hospital beds (208 in Quilmes, 200 in Almirante Brown, 
200 in Florencio Varela and 275 in Berazategui).
The percentage of occupancy of beds on August 18, was for ICU, patients with COVID-19 50% and for sus-
pected patients 13%. In GWo 38% COVID-19 patients and 27% suspected patients, and for GW 21% COVID-19 
patients and 20% suspected patients.
This cohort presented an increase exponential since June 2020, similar to that observed in AMBA, in April 8 
we had 15 patients hospitalized, to August 18 there was a total of 235 patients hospitalized.
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Of the 1495 patients, 690 (46%) cases were discharged to their home, 140 (9%) subjects were discharged 
extra-hospital isolation, 155 (10%) individuals were transferred out of southeast network, and 364 (24%) patients 
remain hospitalized (Table 1).
A total of 826/1429 (58%) patients were men, and the mean age (SD) was 48.9 (15.59) years (Table 2). Of total 
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Figure 1.  Availability of beds in Southeast Network since March 2020 to August 2020. Availability of beds 
by area, in Intensive Therapy Unit (ITU) stay, or General Ward with oxygen therapy (GWo), or General Ward 
(GW) stay. And percentage of increase in beds from March to September.
Table 1.  Follow up of Patients Hospitalized With Coronavirus Disease in Health Centers of Southeast 
Network.
Follow up of patients hospitalized No. (%)
Discharge Home 690 (46)
Discharge Extra-hospital isolation 140 (9)
Transfer out of Southeast network (SN) 155 (10)
Remain Hospitalized 364 (24)
Deaths 146 (10)
Total 1495
Table 2.  Characteristics of Patients Hospitalized with Coronavirus Disease 2019 in Health Centers of 
Southeast Network. 1 Patients with at least one registered pre-existing disease. 2 Total pre-existing diseases 
registered, some patients had more than one disease. Characteristics of Patients Hospitalized with Coronavirus 




Age, mean (SD) 48.9 (15.59)
Pre-existent  diseases1 1012 (81)
1Pre-existent diseases No. (%)
Hypertension 259 (21)
Mellitus diabetes 187 (15)
Chronic lung disease 101 (8)
Cardiovascular disease 92 (7)
Severe obesity 90 (7)
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(81%) patients with chronic comorbidities. A total of 191 patients (13%) were hospitalized in ITU (Table 2), of 
this group 121 (63%) presented serious clinical risk, 170 (89%) subjects had at least one pre-existing disease, 
most frequent were hypertension and diabetes, and 77 (42%) patients had , it was unknown for 8 patients. In 
GWo, 1109 (74%) patients were admitted, with serious clinical risk 60 (5%) subjects, 752 (80%) patients with 
pre-existing disease, the most frequent were obesity, diabetes and hypertension, whereas health history was 
unknown for 166 (15%) patients; and 461 (44%) patients had safe discharge, it was unknown for 58 patients 
(5%). And in GW, 195 (13%) patients were admitted, with serious clinical risk 6 (3%) subjects, 90 (73%) patients 
with pre-existing disease, the most frequent were diabetes and hypertension and chronic pulmonary disease, it 
was unknown for 72 (37%) patients; and 116 (65%) cases presented safe discharge, it was unknown for 16 (8%) 
patients (Table 2).
The mortality of the cohort was 9.77% (146 of 1495) patients. Mortality was higher for male patients 63% 
(92 of 146), but not significant (p = 0.078), also for patients aged 65 or more (OR 5.09; 95% CI 3.42/7.57), was 
the variable with the greatest weight in the logistic regression, and for those had some pre-existing disease (OR 
2.61; 95% CI 1.63/4.19). It was unknown for 22 (15%) patients (Table 3). The hypertension, chronic lung disease, 
and cardiovascular disease through logistic regression showed higher risk (Table 4).
In this group, hospitalized in ITU 73% (107) cases, 24% (35) patients in GWo and 3% (4) patients in GW. The 
percentage of mortality was 15% regarding the total number of discharges (976) patients. Mortality compared 
between populations with safe discharge with those who did not safe discharge not observed statistically dif-
ference (p = 0.994).
During the study period, total 3741 patients were admitted to the SN, 1495 patients (40%) with lab-confirmed 
COVID-19; 1262 patients (33%) were suspected COVID-19; and 984 (26%) were patients with other pathologies.
Discussion
In this cohort investigation, NS was involved in 1495 cases hospitalized. In Argentina a total of 312,659 cases 
were reported in this period, no discriminated between patients hospitalized and  outpatients15. We reviewed 
the indexed and non-indexed publications on hospitalized patients with a diagnosis of COVID-19 in Argentina, 
and we have found some works that were published after we sent our manuscript. This pulbications that present 
a selection of the studied population different from our work, however the results in relation to risk factors and 
mortality are similar to our  findings16–18, presents an perspective different like the one carried out by us.
Table 3.  Mortality, characteristics of this populations, risk factors. *Compared deceased patients (146) vs total 
population with information on the history of pre-existing disease (1012). **Odds Ratio for Age group (65 or 
more/up to 64).
Mortality No. (%) All patients 146 (9.8)
Chi Square Test (Total Patients/Mortality 
Patients) Odds Ratio 95% CI (Lower/Upper)
Gender 92(Male)/51(Female) p = 0.078
Pre- existing diseases# 117 (94) p < 0.001 2.61* (1.63/4.19)
Age. mean (SD) 60 (14) p < 0.001 5.09** (3.42/7.57)
Safe discharge 66 (12) p = 0.994
#Severe obesity 6 (7.8) p = 0.276
#Immunosuppression 5 (20.8) p = 0.157
#Hypertension 51 (23.9) p < 0.001 3.132 (2.144—4.574)
#Cancer 3 (11.5) p = 0.985
#Mellitus diabetes 33 (21.3) p < 0.001 2.358 (1.532—3.628)
#Cardiovascular disease 23 (28.4) p < 0.001 3.82 (2.015—5.676
#Chronic lung disease 19(22.9) p < 0.001 2.438 (1.415—4.201)
#Chronic renal disease 5 (17.9) p = 0.301
Table 4.  Mortality, Logistic Regression, Compared deceased patients (146) vs total population included 
missing cases.
Variables Sig Exp(B) (95 CI Lower/Upper
Hypertension 0.004 1.920 (1232/2.993
Chronic lung disease 0.020 2.019 (1.117/3.648)
Cardiovascular disease 0.009 2.128 (1.207/3.752)
Pre-existing diseases 0.019 2.072 (1.126/3.813)
Age group 0.000 3.493 (2.273/5.368)
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The health system in our region allocates 60% of the availability of beds in ITU to the pandemic, among sus-
pected and confirmed patients, and almost 50% for General Ward. This situation certainly has a strong impact 
on the care of patients with other diseases who receive regular care, not yet studied this effect.
The cohort was characterized by average age of 48.9 years, similar to reported in  Argentina7, but are 
younger, compared to the most publications of developed  countries19–21 . May be due to the gap between devel-
oped and developing countries in relation to population pyramid profile, in Latin America, also observed in 
Argentina, those under 15 years of age represent 25.2%, and the population and those over 60 years are 15.1%18. 
While in developed countries, those over 60 reach, in some countries, double that percentage 18. More than half 
of patients were men, as well as referred most authors 7,19.
The cohort was characterized by substantial chronic health comorbidities, 1012 (81%) patients, these observa-
tions are consistent with most of reports every region of the world 19–21.
The study population included patients who live in conditions of vulnerability, we compared particularly 
with those who don’t have housing and lived in worse  conditions22,23. This condition of extreme vulnerability 
does not necessarily mean a risk factor neither more severe illness nor mortality. Could be due, to despite that 
still economic and social deficits of health system, major increase the number of hospital beds in the area, and 
optimize the resource utilization of ICUs can effectively to offer a response to our people.
The mortality of the cohort was 9.77%, was higher for patients aged 65 or more (OR 5.09), and for those had 
some pre-existing disease (OR 2.61). The hypertension, chronic lung disease, and cardiovascular disease through 
logistic regression showed higher risk. These observations are consistent with reports demonstrating older per-
sons, and those with comorbidities have the highest risk of mortality related to COVID-1924,25. However, unlike 
other reports from developed or some developing countries, the mortality in our study is  lower20,21,24,25. This 
finding may be related, to what we have already commented, the age of our cohort is younger than other pub-
lished series, and the health system was able to respond to the demand. On the other hand, old individuals live 
at home and generally receive family support, which has allowed them to maintain social  isolation26.
The creation of the Network to link all the health centers in the region and clinic records makes for a valuable 
public health investigative tool that can help to define clinical strategies for patients care during the pandemic.
Conclusions
In this cohort involving SN response, in a developing country, urban poverty in Argentina remains (40.9% of 
population), while extreme poverty increased to 10.5% in 2020. In SN the the socio-economic situation is even 
worse, especially in the care of vulnerable patients.
The strategies that we use in our experience to face the pandemic, in particular the increase in the availability 
of the number of available hospital beds and human and technical resources since the beginning of the pandemic 
resulted essential in order to respond to the serious health situation. We consider that may be useful for other 
regions with similar socio-economic conditions.
Data availiability
The Availability of data and materials section refers to the raw data used in your study and presenting tables and 
figures is not sufficient to state that all data is contained within the manuscript and additional files. Please only 
use this statement if you have indeed provided all raw data on which your study is based. We strongly encour-
age all authors to share their raw data, either by providing it in a supplementary file or depositing it in a public 
repository and providing the details on how to access it in this section. If you do not wish to share your data, 
please clearly state this in this section along with a justification. Data availability statements can take one of the 
following forms (or a combination of more than one if required for multiple datasets): The a part of the datasets 
generated and/or analysed during the current study are available in the Hospital El Cruce N Kirchner repository 
(https:// repos itorio. hospi talel cruce. org/ xmlui/ handle/ 12345 6789/ 115). The other datasets used and/or analysed 
during the current study available from the corresponding author on reasonable request.
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